MilagroAI COVID–19 Solutions: Rapidly and easily customized, nimble and accurate.

Medical knowledge and protocols with respect to Covid change quickly. There is a possibility of a second wave, with or without an unpredictable mutation. If there is a situation that threatens to overwhelm your facilities, clinicians or resources, algorithms that monitor your patients 24-7 with deep clinical understanding, while crucial at all times, become required. 

Our “second wave” Covid solution, is flexible and customizable to meet complex new conditions, new knowledge, and your own specific requirements. We will meet with your top docs and be ready to customize a solution to any new challenge within days.

COVID-19, caused by the SARS-CoV2 virus, is a potentially fatal disease that represents a major global public health concern. COVID-19 infects the lower respiratory tract and causes pneumonia in humans, with symptoms that initially appear mild, but may rapidly progress to a lethal disease of hyperinflammation and respiratory dysfunction.

SARS-CoV2 infection and disease can be approximately divided into four phases:

  • Asymptomatic phase with or without detectable virus
  • Non-severe symptomatic phase with upper airway involvement
  • Severe, potentially lethal disease with hypoxia, infiltrates in the lung, and progression to acute respiratory distress syndrome
  • Hypercoagulation as a result of cytokine storm with increased risk for stroke, pulmonary embolism, deep vein thrombosis and multi-organ failure

Early identification of which patients are at high risk for progression to severe disease is important both for medical care and resource utilization.  MilagroAI has leveraged its unique ability to develop highly accurate predictive algorithms, in a matter of days from relatively small data sets, to produce a set of highly customizable COVID specific algorithms that arm physicians and hospitals with the critical intelligence needed to optimize clinical care, reduce ICU admissions and manage ventilator usage.